Trial Profile
Effect of deferasirox given before transplant in iron overloaded severe apastic anemia patients undergoing Allogeneic Stem Cell Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 16 Apr 2015 New trial record